Massive red flag: NanoViricides Signs Agreement with St. Jude Children’s Research Hospital for furt

Massive red flag: NanoViricides Signs Agreement with St. Jude Children's Research Hospital for furt

Eye Herpes | Ocular Herpes | Do you have Herpes in or … Once the final decision is made, we should be in TOX testing soon. Seymour made an interesting observation: Nanoviricides is only two years old. It is, as far as I can tell, the only commercial nanoparticle production facility operating today. That would more than service the 48,000 new and reactivated cases. I’m sure there could be lots of good reasons to just pursue a single virus…but was a dual-acting viricide considered, and what was the thought process? I recall the sale was PR’d and done shortly after the rehab was completed and was priced at cost of the building and rehab…I recall no acrimony or forced sale by angry investors…I know he used to be a great advocate and influenced many people to invest…I remember a positive PR and a ribbon cutting ceremony with the governor and senator in attendance around the time of sale.

Massive red flag: NanoViricides Signs Agreement with St. Jude Children's Research Hospital for furt
Unfortunately, the universities don’t have this equipment! As April is National STD Month, I would like to ask you to please do a segment on herpes. Dr. Depending on what the company can charge, that still could amount to enough to make a business. Been dead for years now. And I have TMJ. But for me, with the outbreak on the lid, the l-lysine alone worked.

Yes, I put off my foot dr appointment because of too many dr appointments. Some doctors german cure for herpes corticosteroids, such as Scopace, to reduce the severity of the symptoms, especially the event of stromal keratitis . If the company were to delay development of a herpes drug to now pursue another flu drug, that would be a bad omen indeed. It’s not clear to me that’s what’s going on here. NNVC’s management has told Newsletter writer Stephen Petranek (Breakthrough Technology Alert) that they hope/intend to be in human trials for a herpes drug by the end of 2016. I suspect they will be late, but it will be interesting to watch what is announced with regard to ocular HerpeCide animal testing results intended to facilitate the selection of a lead drug candidate. Dr.

Seymour’s optimistic schedule presented in San Francisco in January indicates we should have made an informed lead drug selection within the next two months. I suspect it will be late…but I’m curious how late. As for NNVC becoming a penny stock (share price dipping below a dollar), it’s certainly possible…not a huge stretch as it was below a dollar as recently as December 2015. Professionals built the Titanic.

You may also like

Massive red flag: NanoViricides Signs Agreement with St. Jude Children’s Research Hospital for furt

Massive red flag: NanoViricides Signs Agreement with St. Jude Children's Research Hospital for furt

Hello everyone! They are 2 black kitten sisters, about 10 weeks old. It basically constitutes, IMHO, a second desperation attempt to get the share price up as much as possible to enable a secondary in order to (hopefully) give the company enough time to solve the critical manufacturing problems. FluCide delays…point well taken. It is caused by the type 1 herpes simplex virus, and is a common, recurrent viral infection affecting the eyes. So, I am not too worried that NNVC and Theracour only have a deal for about 10 or so viruses. Thus, the first commercialization strategy of becoming a “proof of concept” company failed.

Massive red flag: NanoViricides Signs Agreement with St. Jude Children's Research Hospital for furt
This facility is not large enough to manufacture sufficient Flucide to handle the enormous demand for an effective influenza medication, but it is big enough to make more than enough material for the upcoming toxicity studies. And that still leaves unserviced the much bigger market for a cream to treat shingles and oral / genital herpes. (Or it has room for three to four 50-liter bioreactors.) With eight 5-liter bioreactors it could make (200 g/batch)(8 bioreactors)(52 weeks/year)/(3 weeks/batch). NNVC had the money to buy it, but it made some sense to raise additional money to buy the facility. We have had to adapt to the changing conditions. Most people contract oral herpes when they are children by receiving a kiss from a friend or relative. CORL understands industry’s timeline-driven culture and can collaborate with industry via fee-for-service agreements.

There are 48,000 annual cases of ocular herpes in the US alone. I am going to delete all of my friends on Facebook, and send them all messages telling them that they know why I did it, and they should watch their back. I’m waiting on a panoramic x-ray right now for the dentist and rheumy to take a look at so they can decide what is causing the problems with my jaw. I started taking it at the first sign of that burning, itchy feeling. I totally understand about the appointments, but you need to see an ophthalmologist ASAP. For example, it be justified to start topical antivirals if a patient manifests lid vesicles and early, poorly differentiated dendrites, thus blurring the lines between simplex and zoster. I’m not saying this company is a safe investment, only that it has more chance of surviving than I think you’re giving it.

And despite the structure, it is still in Diwan’s interest to make this company succeed (if he can).

You may also like